HW English
News Report

Coronavirus Update: After FabiFlu, Now Potential COVID-19 Drug Covifor and Cipremi To Hit The Market

While Glenmark Pharmaceuticals has launched favipiravir under the brand name FabiFlu for treatment of mild to moderate cases of Covid-19, Cipla and Hetero Labs have received approvals from the Drug Controller General of India to launch generic versions of Remdesivir under the brand names Cipremi and Covifor respectively. #FabiFlu #Covifor #Cipremi

Related posts

Delhi Assembly Elections: Why Are BJP & Congress Using ‘Bihar’ Connection?

Arti Ghargi

Did politicians kill River Ganga’s son GD Agarwal?

Anusha Bhattacharya

No need for a separate law on Lynching, Says Central Government

Anusha Bhattacharya